This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v., Washington University. Active years: 2018.
Company Filing History:
1 out of 4,921 
1 out of 1,379 
Years Active: 2018
Title: The Innovations of Stefan Chabierski
Introduction
Stefan Chabierski is a notable inventor based in Munich, Germany. He has made significant contributions to the field of virology, particularly in the area of flavivirus infections. His work has implications for both research and practical applications in medical diagnostics.
Latest Patents
Chabierski holds a patent for "Distinguishing flavivirus infection using a recombinant mutant envelope protein." This invention relates to mutant peptides of the E protein of the West Nile virus and other flaviviruses. It is useful for discriminating flaviviral infections, as well as for the development of related kits, methods, and uses.
Career Highlights
Throughout his career, Chabierski has worked with prominent institutions, including the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. and Washington University. His experience in these organizations has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Chabierski has collaborated with esteemed colleagues such as Sebastian Ulbert and Michael S. Diamond. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Stefan Chabierski's innovative work in distinguishing flavivirus infections showcases his expertise and dedication to advancing medical science. His contributions are vital for improving diagnostic methods and understanding viral infections.